Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 2/2012

01.08.2012 | Gynecologic Oncology

Characteristics and therapy of premenopausal patients with early-onset breast cancer in Germany

verfasst von: Constanze Banz-Jansen, Alessa Heinrichs, Marianne Hedderich, Annika Waldmann, Christine Dittmer, Berit Wedel, Imke Mebes, Klaus Diedrich, Dorothea Fischer

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The objective of the study is to investigate what kind of tumors young, premenopausal breast cancer patients in Germany show at diagnosis and how they are treated adjuvantly in comparison with a normally distributed cohort.

Methods

The study describes the data of 535 patients who were treated adjuvantly between 2002 and 2006 and participated in a resident mother–child program for rehabilitation (Groemitz cohort). The data includes TNM categories, biology of tumor and therapies. This population is being compared to an age-heterogeneous cohort from the state of Schleswig-Holstein and the DMP-report of the state of North Rhine-Westphalia.

Results

45.8 % of the patients were diagnosed with tumor category pT1, 37 % pT2, 7.3 % pT3 and 1.9 % pT4. 5 % had merely DCIS. 48.8 % of the patients were pN0, 31.4 % pN1 and 17.4 % had a more intense manifestation of lymph nodes. 43.5 % of the tumors showed a grading classified as G3, 64.3 % were estrogen and progesterone hormone receptor positive and 26.2 % Her2 positive. 21 % of the examined cohort members/patients showed a triple negative carcinoma. 59.1 % of the patients with pT1 underwent breast-conserving surgery, 56.1 % of those with pT2 and 25.6 % of those with pT3. Overall 31.0 % of the women received mastectomy and 14.8 % received mastectomy with subsequent reconstruction. 97.6 % of the patients received axillary surgery, 89.9 % chemotherapy. Overall 23.7 % of the patients received their treatment in connection with clinical studies. 95.3 % of the patients with hormone receptor positive tumor received endocrine therapy, 61.3 % of them with GnRH-analogs. In comparison with the OVIS and DMP cohorts patients of the Groemitz cohort were on average 20 years younger. Their tumors were of bigger size and had more often reached the axillary lymph nodes (pN0 48.8 % Groemitz/62.0 % OVIS/66.7 % DMP). The hormone receptor status was more often negative (35.7/16.6/16.5 %) and tumor grading higher (G3 43.5/29.0/28.5 %). Surgery was more extensive even with small tumors (breast conserving surgery with tumor stage pT1 59.1/81.2/77.6 %) and axillary surgery was performed more often in the young collective (97.6/89.3/62.5 %). More patients of the young collective received chemotherapy (89.9/58.4 %/unknown) and more patients of the young collective with hormone receptor positive tumor received endocrine therapy (95.3/77.4/90.6 %).

Conclusion

Our study shows that young breast cancer patients in Germany can be regarded as a special group. At the time of diagnosis the tumor has frequently reached a more advanced stage, and carcinomas are more aggressive. Operative and medical treatment will often be more aggressive.
Literatur
1.
Zurück zum Zitat Katalinic A, Rawal R (2008) Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy. Breast Cancer Res Treat 107:427–430PubMedCrossRef Katalinic A, Rawal R (2008) Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy. Breast Cancer Res Treat 107:427–430PubMedCrossRef
2.
Zurück zum Zitat Katalinic A, Lemmer A, Zawinell A, Rawal R, Waldmann A (2009) Trends in hormone therapy and breast cancer incidence—results from the German Network of Cancer Registries. Pathobiology 76:90–97PubMedCrossRef Katalinic A, Lemmer A, Zawinell A, Rawal R, Waldmann A (2009) Trends in hormone therapy and breast cancer incidence—results from the German Network of Cancer Registries. Pathobiology 76:90–97PubMedCrossRef
3.
Zurück zum Zitat DeMichele A, Putt M, Zhang Y, Glick JH, Norman S (2003) Older age predicts a decline in adjuvant chemotherapy recommendations for patients with breast carcinoma: evidence from a tertiary care cohort of chemotherapy-eligible patients. Cancer 97:2150–2159PubMedCrossRef DeMichele A, Putt M, Zhang Y, Glick JH, Norman S (2003) Older age predicts a decline in adjuvant chemotherapy recommendations for patients with breast carcinoma: evidence from a tertiary care cohort of chemotherapy-eligible patients. Cancer 97:2150–2159PubMedCrossRef
4.
Zurück zum Zitat Kosiak B, Sangl J, Correa-de-Araujo R (2006) Quality of health care: what do we know? Womens health Issues 16:89–99PubMedCrossRef Kosiak B, Sangl J, Correa-de-Araujo R (2006) Quality of health care: what do we know? Womens health Issues 16:89–99PubMedCrossRef
5.
Zurück zum Zitat Waldmann A, Pritzkuleit R, Raspe H, Katalinic A (2008) Guideline-compatible treatment of breast cancer patients. Dtsch Ärztebl Int 105(18):337–343PubMed Waldmann A, Pritzkuleit R, Raspe H, Katalinic A (2008) Guideline-compatible treatment of breast cancer patients. Dtsch Ärztebl Int 105(18):337–343PubMed
7.
Zurück zum Zitat Robles-Castillo J, Ruvalcaba-Limon E, Maffuz A, Rodriguez-Cuevas S (2011) Breast cancer in Mexican women under 40. Ginecol Obstet Mex 79(8):482–488PubMed Robles-Castillo J, Ruvalcaba-Limon E, Maffuz A, Rodriguez-Cuevas S (2011) Breast cancer in Mexican women under 40. Ginecol Obstet Mex 79(8):482–488PubMed
8.
Zurück zum Zitat Kheirelseid EH, Boggs JM, Curran C, Glynn RW, Dooley C, Sweeney KJ, Kerin MJ (2011) Younger age as a prognostic indicator in breast cancer: a cohort study. BMC Cancer 11:283CrossRef Kheirelseid EH, Boggs JM, Curran C, Glynn RW, Dooley C, Sweeney KJ, Kerin MJ (2011) Younger age as a prognostic indicator in breast cancer: a cohort study. BMC Cancer 11:283CrossRef
9.
Zurück zum Zitat Tarone RE (2006) Breast cancer trends among young women in the United States. Epidemiology 17(5):588–590PubMedCrossRef Tarone RE (2006) Breast cancer trends among young women in the United States. Epidemiology 17(5):588–590PubMedCrossRef
10.
Zurück zum Zitat Gonzales-Angulo AM, Broglio K, Kau SW, Eralp Y, Erlichman J, Valero V, Theriault R, Booser D, Buzdar AU, Hortobagyi GN, Arun B (2005) Women age < or = 35 years with primary breast carcinoma: disease features at presentation. Cancer 103(12):2466–2472CrossRef Gonzales-Angulo AM, Broglio K, Kau SW, Eralp Y, Erlichman J, Valero V, Theriault R, Booser D, Buzdar AU, Hortobagyi GN, Arun B (2005) Women age < or = 35 years with primary breast carcinoma: disease features at presentation. Cancer 103(12):2466–2472CrossRef
11.
Zurück zum Zitat Rapiti E, Fioretta G, Verkooijen HM, Vlastos G, Schäfer P, Sappino AP, Kurtz J, Neyroud-caspar I, Bouchardy C (2005) Survival of young and older breast cancer patients in Geneva from 1990 to 2001. Eur J Cancer 41(10):1446–1452PubMedCrossRef Rapiti E, Fioretta G, Verkooijen HM, Vlastos G, Schäfer P, Sappino AP, Kurtz J, Neyroud-caspar I, Bouchardy C (2005) Survival of young and older breast cancer patients in Geneva from 1990 to 2001. Eur J Cancer 41(10):1446–1452PubMedCrossRef
12.
Zurück zum Zitat Love RR, Duc NB, Dinh NV, Quy TT, Xin Y, Havighurst TC (2002) Young age as an adverse prognostic factor in premenopausal women with operable breast cancer. Clin Breast cancer 2(4):294–298PubMedCrossRef Love RR, Duc NB, Dinh NV, Quy TT, Xin Y, Havighurst TC (2002) Young age as an adverse prognostic factor in premenopausal women with operable breast cancer. Clin Breast cancer 2(4):294–298PubMedCrossRef
13.
Zurück zum Zitat Elkum N, Dermime S, Ajarim D, Al-Zahrani A, Alsayed A, Tulbah A, Al Malik O, Alshabanah M, Ezzat A, Al-Tweigeri T (2007) Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: the Saudi Arabia experience. BMC Cancer 7:222PubMedCrossRef Elkum N, Dermime S, Ajarim D, Al-Zahrani A, Alsayed A, Tulbah A, Al Malik O, Alshabanah M, Ezzat A, Al-Tweigeri T (2007) Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: the Saudi Arabia experience. BMC Cancer 7:222PubMedCrossRef
14.
Zurück zum Zitat Loibl S, Amant F, Kaufmann M, Ring A, Han S, Giermek J, Fehm T, Bontenbal M, Heinrigs M, Lenhard M, Scherr I, Mehta K, von Minckwitz G (2010) Patients with breast cancer during pregnancy-results from a prospective and retrospective registry (GBG20/BIG02-03). Cancer Res 70(24):S6–S12CrossRef Loibl S, Amant F, Kaufmann M, Ring A, Han S, Giermek J, Fehm T, Bontenbal M, Heinrigs M, Lenhard M, Scherr I, Mehta K, von Minckwitz G (2010) Patients with breast cancer during pregnancy-results from a prospective and retrospective registry (GBG20/BIG02-03). Cancer Res 70(24):S6–S12CrossRef
15.
Zurück zum Zitat El-Saghir NS, Seoud M, Khalil MK, Charafeddine M, Salem ZK, Geara FB, Shamseddine AI (2006) Effects of young age at presentation on survival in breast cancer. BMC Cancer 6:194PubMedCrossRef El-Saghir NS, Seoud M, Khalil MK, Charafeddine M, Salem ZK, Geara FB, Shamseddine AI (2006) Effects of young age at presentation on survival in breast cancer. BMC Cancer 6:194PubMedCrossRef
16.
Zurück zum Zitat O‘Shaughnessy J, Osborne C, Pippen JE, Yoffe M, Patt D, Rocha C, Koo IC, Sherman BM, Bradley C (2011) Iniparib plus chemotherapy in metastatic triple-negative breast cancer. N Engl J Med 364(3):205–214PubMedCrossRef O‘Shaughnessy J, Osborne C, Pippen JE, Yoffe M, Patt D, Rocha C, Koo IC, Sherman BM, Bradley C (2011) Iniparib plus chemotherapy in metastatic triple-negative breast cancer. N Engl J Med 364(3):205–214PubMedCrossRef
17.
Zurück zum Zitat de Bock GH, van der Hage JA, Putter H, Bonnema J, Bartelink H, van de Velde CJ (2006) Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: long-term results of European Organisation for Research and Treatment of Cancer Studies. Eur J Cancer 42(3):351–356PubMedCrossRef de Bock GH, van der Hage JA, Putter H, Bonnema J, Bartelink H, van de Velde CJ (2006) Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: long-term results of European Organisation for Research and Treatment of Cancer Studies. Eur J Cancer 42(3):351–356PubMedCrossRef
Metadaten
Titel
Characteristics and therapy of premenopausal patients with early-onset breast cancer in Germany
verfasst von
Constanze Banz-Jansen
Alessa Heinrichs
Marianne Hedderich
Annika Waldmann
Christine Dittmer
Berit Wedel
Imke Mebes
Klaus Diedrich
Dorothea Fischer
Publikationsdatum
01.08.2012
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 2/2012
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-012-2291-9

Weitere Artikel der Ausgabe 2/2012

Archives of Gynecology and Obstetrics 2/2012 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.